MyFinsight
Home
Blog
About
Proceeds from maturity of
fixed deposits
$443,395
something is missing
$21,008
Net cash generated
from/(used in) investing...
$416,140
(1041.96%↑ Y/Y)
Net cash generated
from/(used in) financing...
$13,607
(819.95%↑ Y/Y)
Canceled cashflow
$27,255
Canceled cashflow
$7,401
Net change in cash
and cash...
-$6,032
(99.55%↑ Y/Y)
Canceled cashflow
$429,747
Trade and other
receivables
$553,575
(50.29%↑ Y/Y)
something is missing
$143,202
Inventories
$33,360
(119.28%↑ Y/Y)
Trade and other
payables
$24,596
(121.85%↑ Y/Y)
Tax liabilities
$22
Payment for acquisition
of right-of-use...
$21,008
Change in fixed
deposits placed with...
$5,997
(-80.80%↓ Y/Y)
Purchase of plant and
equipment
$250
(-99.18%↓ Y/Y)
Advance from/
(repayments to) directors
-$5,584
(-303.18%↓ Y/Y)
Repayment of finance lease
liabilities
$1,817
Net cash used in
operating activities
-$422,491
(72.95%↑ Y/Y)
Canceled cashflow
$754,755
Foreign currency
translation adjustment
-$13,288
(-105.15%↓ Y/Y)
Allowances for expected
credit losses
$68,164
(69.88%↑ Y/Y)
Depreciation of property,
plant and equipment
$28,065
(-48.45%↓ Y/Y)
Amortization of operating
lease rou assets
$15,604
(-42.87%↓ Y/Y)
Amortization of finance lease
rou assets
$2,723
Operating loss before
working capital changes
-$911,156
(19.99%↑ Y/Y)
Canceled cashflow
$114,556
Other assets
-$249,999
Operating lease
liabilities
-$16,026
(-19.59%↓ Y/Y)
Advance payment from
customer
-$65
(99.92%↑ Y/Y)
something is missing
-$621,135
Net loss
$286,451
Recoveries for expected
credit losses
-$118,126
(-224.46%↓ Y/Y)
Back
Back
Cash Flow
BioNexus Gene Lab Corp (BGLC)
BioNexus Gene Lab Corp (BGLC)
source: myfinsight.com